The largest proton therapy users community is meeting to achieve excellence

Proton therapy

IBA organizes its 7th annual Proteus® User Meeting in Stockholm, Sweden

Louvain-la-Neuve, Belgium, March 8, 2018– IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions, is hosting its 7th annual Proteus® User Meeting from March 9 to March 11, in Stockholm, Sweden. As the world’s leading vendor of proton therapy systems, with more than 24 sites in operation and another 23 under construction, IBA is continuously gathering input from its proton therapy users.

The users’ community is expanding every year. This year IBA will be welcoming more than 110 users, making IBA’s proton therapy community the largest in the industry. There will be several new pioneers coming this year among which the first one to develop a proton therapy center in Africa.  The number of centers in operation, equipped by IBA, keeps growing, enabling more and more patients all over the world to have access to this cutting-edge technology.

This year’s User Meeting will be hosted by Skandion Clinic, in Uppsala, Sweden, a city closely related to the very origins of proton therapy. The Gustaf Werner Institute was actually one of the first facilities to use proton therapy to irradiate cancer in 1957.

This three-day meeting is a unique platform to gather IBA customers and exchange feedbacks that contribute to increase performance of operations and maintenance of the centers. This is also the opportunity to collect valuable inputs from clinicians to drive future technological developments. IBA customers, the most experienced practitioners in the field of proton therapy, will discuss clinical studies, treatment protocol developments, new indications and share their experience to facilitate a proper adoption of proton therapy.

Olivier Legrain, Chief Executive Officer, IBA: “The User Meeting is a key event for IBA. It helps us to understand the needs of our clinical partners. With 24 treating centers versus five for our main competitor, we gather extremely valuable feedbacks. These intense interactions allow us not only to stay ahead of our competitors in terms of product performance and new development, but also to support our customers in improving access to proton therapy to more patients who could benefit from it.”

Peter Daneryd,[LH1]  Chief Executive Officer, Skandion Clinic: “We are very proud and honored that IBA has chosen to hold the 2018 User Meeting in Stockholm and Uppsala. This meeting has really developed over the years into an annual reference meeting for IBA users, and we are looking forward to three days of multi-professional interaction”, says Peter Daneryd, CEO, MD PhD, Joint Commission of County Councils for Advanced Radiotherapy/the Skandion Clinic. “The Skandion Clinic is the first proton therapy center in the Nordics, and a true national collaborative effort that makes it a national concern of great importance.”

About IBA

IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,500 people worldwide, IBA has installed systems across the world.

IBA is listed on the pan-European stock exchange NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More information can be found at:

About Skandion Clinic

The Skandion Clinic is Scandinavia’s first modern clinic for proton therapy. The Skandion Clinic is a national project, established in collaboration between the seven Swedish County Councils with University hospitals.

In 2006, the County Councils formed the Joint Authority of County Councils for Advanced Radiotherapy. The Joint Authority has the duty to build and operate the clinic, create conditions for optimal treatment and develop and evaluate the clinical activities.

More information can be found at:

For further information, please contact:

Daniel Ernult
Proton Therapy Marketing Associate
+32 10 201 287